Don’t Ignore The Fact That This Insider Just Sold Some Shares In UnitedHealth Group Incorporated (NYSE:UNH) – Simply Wall St

Some UnitedHealth Group Incorporated (NYSE:UNH) shareholders may be a little concerned to see that the Non-Executive Chairman, Stephen Hemsley, recently sold a substantial US$25m worth of stock at a price of US$421 per share. However, that sale only accounted for 3.2% of their holding, so arguably it doesn’t say much about their conviction.

View our latest analysis for UnitedHealth Group

The Last 12 Months Of Insider Transactions At UnitedHealth Group

In fact, the recent sale by Non-Executive Chairman Stephen Hemsley was not their only sale of UnitedHealth Group shares this year. They previously made an even bigger sale of -US$32m worth of shares at a price of US$330 per share. That means that an insider was selling shares at slightly below the current price (US$409). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it’s only a weak signal. This single sale was just 4.5% of Stephen Hemsley’s stake.

Over the last year we saw more insider selling of UnitedHealth Group shares, than buying. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

NYSE:UNH Insider Trading Volume July 20th 2021

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. UnitedHealth Group insiders own 0.5% of the company, currently worth about US$2.0b based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

What Might The Insider Transactions At UnitedHealth Group Tell Us?

Insiders haven’t bought UnitedHealth Group stock in the last three months, but there was some selling. Zooming out, the longer term picture doesn’t give us much comfort. It is good to see high insider ownership, but the insider selling leaves us cautious. While we like knowing what’s going on with the insider’s ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. You’d be interested to know, that we found 2 warning signs for UnitedHealth Group and we suggest you have a look.

Of course UnitedHealth Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

When trading UnitedHealth Group or any other investment, use the platform considered by many to be the Professional’s Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

Leave a Reply

Your email address will not be published. Required fields are marked *